FDA
approval
· 2019-12-20
FDA Approved: GENOSYL — Original Application (VERO BIOTECH, INC.)
Summary
FDA approved GENOSYL (nitric oxide) from Vero Biotech, Inc., an inhaled nitric oxide therapy for term and near-term neonates with hypoxic respiratory failure du…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for GENOSYL (NITRIC OXIDE)